Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total
Balance at beginning of period at Dec. 31, 2021	$ 102	$ 399,754	$ (10,869)	$ (2,910)	$ 386,077
Balance (in shares) at Dec. 31, 2021	10,183,730
Increase (Decrease) in Stockholders' Equity
Equity awards issued (in shares)	2,698
Stock-based compensation expense		273			273
Shares acquired to satisfy employee tax withholding requirements on stock awards		(23)			(23)
Shares acquired to satisfy employee tax withholding requirements on stock awards (in shares)	(285)
Common stock dividends			(1,630)		(1,630)
Net (loss) income			269		269
Other comprehensive income (loss)				4,662	4,662
Balance at end of period at Mar. 31, 2022	$ 102	400,004	(12,230)	1,752	389,628
Balance (in shares) at Mar. 31, 2022	10,186,143
Balance at beginning of period at Dec. 31, 2022	$ 102	401,370	(11,486)	7,283	397,269
Balance (in shares) at Dec. 31, 2022	10,192,416
Increase (Decrease) in Stockholders' Equity
Equity awards issued (in shares)	3,278
Stock-based compensation expense		503			503
Shares acquired to satisfy employee tax withholding requirements on stock awards		(33)			(33)
Shares acquired to satisfy employee tax withholding requirements on stock awards (in shares)	(488)
Common stock dividends			(1,835)		(1,835)
Net (loss) income			(5,777)		(5,777)
Other comprehensive income (loss)				(2,467)	(2,467)
Balance at end of period at Mar. 31, 2023	$ 102	$ 401,840	$ (19,098)	$ 4,816	$ 387,660
Balance (in shares) at Mar. 31, 2023	10,195,206